Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Hemogenyx Pharmaceuticals (HEMO) Share Price

Price 966.00p on 07-04-2026 at 18:35:11
Change -5.00p -0.53%
Buy 999.00p
Sell 891.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 2,000.00 at 938.784p
Day's Volume: 67,642
Last Close: 945.00p
Open: 901.00p
ISIN: GB00BQVXM815
Day's Range 901.00p - 966.00p
52wk Range: 124.50p - 1,790.00p
Market Capitalisation: £62.07m
VWAP: 931.02339p
Shares in Issue: 6.43m

Sector: Medicine and Biotech

Hemogenyx Pharmaceuticals (HEMO) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 2,000 938.784p Ordinary
 16:25:30 - 07-Apr-26
Sell* 5 939.00p Ordinary
 16:20:46 - 07-Apr-26
Sell* 18 939.00p Ordinary
 16:20:14 - 07-Apr-26
Sell* 200 895.00p Ordinary
 16:20:14 - 07-Apr-26
Sell* 179 939.5352p Ordinary
 16:14:15 - 07-Apr-26
Sell* 2,008 896.2932p Ordinary
 16:08:43 - 07-Apr-26
Sell* 52 939.4812p Ordinary
 15:53:19 - 07-Apr-26
Sell* 67 939.60p Ordinary
 15:49:03 - 07-Apr-26
Sell* 105 940.00p Ordinary
 15:18:54 - 07-Apr-26
Sell* 91 892.00p Ordinary
 15:15:50 - 07-Apr-26
See more Hemogenyx Pharmaceuticals trades

Hemogenyx Pharmaceuticals (HEMO) Share Price History

Time period:
to
Date Open High Low Close Volume
6th Apr 2026 (Mon) 950.00 950.00 950.00 950.00 0
3rd Apr 2026 (Fri) 950.00 950.00 950.00 950.00 0
2nd Apr 2026 (Thu) 932.00 1,000.00 900.00 950.00 7,664
1st Apr 2026 (Wed) 900.00 998.00 900.00 956.00 11,507
31st Mar 2026 (Tue) 892.00 1,000.00 892.00 970.00 25,659
30th Mar 2026 (Mon) 978.00 978.00 918.00 950.00 17,496
27th Mar 2026 (Fri) 992.00 1,035.00 904.00 978.50 7,729
26th Mar 2026 (Thu) 976.00 1,020.00 900.00 1,020.00 23,871
25th Mar 2026 (Wed) 950.00 1,005.00 932.00 1,005.00 9,795
24th Mar 2026 (Tue) 1,020.00 1,020.00 920.00 956.00 18,825
23rd Mar 2026 (Mon) 982.00 1,040.00 936.00 1,040.00 14,342
20th Mar 2026 (Fri) 992.00 1,020.00 876.00 916.00 60,023
19th Mar 2026 (Thu) 1,090.00 1,120.00 998.00 1,015.00 26,529
18th Mar 2026 (Wed) 1,095.00 1,165.00 1,075.00 1,092.50 8,452
17th Mar 2026 (Tue) 1,125.00 1,125.00 1,090.00 1,112.50 19,115
16th Mar 2026 (Mon) 1,150.00 1,150.00 1,150.00 1,135.00 9,406
13th Mar 2026 (Fri) 1,090.00 1,200.00 1,090.00 1,145.00 16,799
12th Mar 2026 (Thu) 1,125.00 1,125.00 1,125.00 1,112.50 8,498
11th Mar 2026 (Wed) 1,125.00 1,160.00 1,050.00 1,090.00 17,572
10th Mar 2026 (Tue) 1,060.00 1,195.00 1,060.00 1,125.00 20,424
9th Mar 2026 (Mon) 922.00 1,150.00 922.00 1,127.50 27,223
See more Hemogenyx Pharmaceuticals price history

Hemogenyx Pharmaceuticals (HEMO) Regulatory News

Date Source Headline
31st Mar 2026 1:22 pm RNS Tech Transfer Completion and Clinical Trial Update
27th Feb 2026 8:10 am RNS Total Voting Rights
24th Feb 2026 7:00 am RNS Holding(s) in Company
23rd Feb 2026 7:00 am RNS Exercise of Warrants and Issue of Equity
10th Feb 2026 3:52 pm RNS Issue of Equity - Correction
10th Feb 2026 7:00 am RNS Issue of Equity
30th Jan 2026 7:00 am RNS Total Voting Rights
12th Jan 2026 7:00 am RNS Holding(s) in Company
22nd Dec 2025 8:00 am RNS Update on Admission of Shares
18th Dec 2025 7:00 am RNS Issue of Equity
See more Hemogenyx Pharmaceuticals regulatory news

Hemogenyx Pharmaceuticals (HEMO) Share News

WINNERS & LOSERS: Tullow falls as oil down; Thungela swings to loss

23rd Mar 2026 11:50

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday. Read More

EARNINGS AND TRADING: Asia Strategic "well-positioned" as loss narrows

10th Feb 2026 19:09

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

LONDON MARKET MIDDAY: FTSE 100 dips as banks slide, mid-caps rise

10th Feb 2026 12:12

(Alliance News) - Stock prices in London were mixed at midday on Tuesday, with the FTSE 100 edging lower as investors weighed a busy flow of company news while mid-cap stocks held up better. Read More

SMALL-CAP WINNERS & LOSERS: Hemogenyx raises funds for phase I trials

10th Feb 2026 10:46

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday. Read More

Hemogenyx secures clearance for pediatric enrolment in leukemia trial

6th Oct 2025 14:22

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has received clearance to begin pediatric enrolment in its phase 1 trial of a leukemia treatment. Read More

See more Hemogenyx Pharmaceuticals news
FTSE 100 Latest
Value10,348.79
Change-87.50

Login to your account

Forgot Password?

Not Registered